It's not just the hotly contested 2.3 percent medical device tax that is presenting a setback to the medical device industry. According to Paul Teitelbaum, managing director with Mesirow Financial's Investment Banking Practice, medical device companies have also been hit hardest by a lack of venture capital funding. DOTmed News spoke with Teitelbaum about why funds are being pulled away from med tech and what it means for the industry.
Image: Paul Teitelbaum courtesy www.dotmed.com
